MARKETWIRE: The approval of Dendreon’s prostate cancer vaccine Provenge in April was a boon for a nascent cancer vaccine industry that had suffered several setbacks, and should lead to an influx of market opportunities and a surge in regulatory activity. READ MORE>
Posts Tagged ‘Provenge’
Provenge approval expected to rejuvenate cancer vaccine industry
Posted in Provenge, tagged advanced prostate cancer, cancer research, cancer vaccine industry, catherise, catheter, catheterisation, Dendreon, MARKETWIRE, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, Provenge, Provenge treatment, URO TODAY on September 12, 2010| Leave a Comment »
Jury still out on how long immuno-therapeutic drugs like Provenge can prolong life
Posted in Provenge, tagged advanced prostate cancer, cancer research, catheter, immuno-therapy, KANSASCITY.COM, large clinical trials, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, prostate treatment, prostate treatment debate, Provenge, Provenge treatment, vaccines on August 21, 2010| Leave a Comment »
KANSASCITY.COM: Researchers can cite anecdotes of cancer patients given months to live who have survived 15 years or longer after receiving vaccines, but so far conclusive evidence from large clinical trials is scant. READ MORE>
Why has it taken so long for prostate cancer cell detector to arrive in Australasia?
Posted in Treatment news, tagged cancer research, catheter, cell search machine, NZ Ministry of Health, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer diagnosis, prostate cancer treatments, prostate treatment, prostate treatment debate, Provenge, Provenge treatment on August 7, 2010| Leave a Comment »
PROSTABLOG NZ: Australian news media are breathlessly reporting that a “new” prostate cancer diagnostic tool, the cell search machine, is being set up in their country for the first time (in Brisbane). READ MORE>
Should we be excited? Yes – that this technology – used in the US for more than five years – is finally appearing in our part of the world (although not yet in NZ).
My gripe is not about the news itself, but the way ill-informed journalists report such announcements, swallowing the official spin without question.
The real story lies in challenging governments over the delays that attach to such breakthroughs making their way Down Under.
Has anyone thought to ask NZ or Australian ministries of health how long it will be before Provenge (a new treatment for advanced prostate cancer) is available here?
Prostate cancer drug Provenge finally starts earning money for its maker
Posted in Provenge, tagged advanced prostate cancer, catheter, Dendreon, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, prostate treatment, prostate treatment debate, Provenge, Provenge treatment, WALL ST JOURNAL on August 6, 2010| Leave a Comment »
WALL ST JOURNAL: New wonder drug for treating advanced prostate cancer, Provenge, is finally making money for its manufacturer, Dendreon Corp. READ MORE>
Since the $93,000 treatment was launched at the beginning of May, doctors have written 500 prescriptions for the treatment, the company disclosed.
Provenge extends prostate patients’ lives about four months – at a cost of $130,000
Posted in Provenge, tagged ABC NEWS, advanced prostate cancer, cancer research, catheter, Dendreon, extending life, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, prostate treatment, prostate treatment debate, Provenge, Provenge treatment on July 31, 2010| Leave a Comment »
ABC NEWS: The new US wonder drug for treating advanced prostate cancer – Provenge – extends life about four months – at a cost of $NZ130,000 ($US93,000).
The makers say it took 15 years to develop, at a cost of $US1.2 billion. READ MORE> and MORE>
Year-long wait for Provenge in US hospitals
Posted in PROSTATE CANCER, Provenge, tagged advanced prostate cancer, BLOOMBERG, catheter, Dendreon Corp, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, Provenge, Provenge treatment on June 29, 2010| Leave a Comment »
BLOOMBERG: Prostate cancer patients seeking Dendreon Corp’s new tumour-fighting vaccine, Provenge, face delays of a year or more as hospital waiting lists dwarf the company’s capacity to produce medicine. READ MORE>
FDA approves Provenge – a breakthrough for men with advanced prostate cancer
Posted in PROSTATE CANCER, Provenge, tagged advanced prostate cancer, catheter, FDA, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, Provenge, Provenge treatment on May 6, 2010| 1 Comment »
PROSTABLOG NZ: At last – the FDA has approved Provenge, the new and highly promising treatment for men with advanced prostate cancer. READ MORE>
Provenge treatment for advanced prostate cancer gets a step closer
Posted in PROSTATE CANCER, Provenge, Treatment news, tagged advanced prostate cancer drug, cancer research, catheter, FDA, New Prostate Cancer Info-link, prostablog, prostate, prostate cancer treatments, prostate treatment, prostate treatment debate, Provenge on November 4, 2009| Leave a Comment »
NEW PROSTATE CANCER INFOLINK: Long-awaited advanced prostate cancer drug Provenge is a step closer to being available with news the manufacturing company has completed its full application to the FDA. READ MORE>
New immunotherapy treatment for advanced prostate cancer now expected to be available by mid-2010
Posted in PROSTATE CANCER, Provenge, Treatment debate, Treatment news, tagged advanced prostate cancer, breast cancer treatment, Dendreon Corp, FDA approval, Herceptin debate, immunotherapy treatment, individual cell-based immunotherapy, individually created, New Prostate Cancer Info-link, NZ's drug approval organisation, Pharmac, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, prostate treatment, prostate treatment debate, Provenge, Provenge treatment, Wall Street Journal on September 26, 2009| 1 Comment »
WALL STREET JOURNAL: Dendreon Corp expects to file for marketing approval for advanced prostate cancer immunotherapy treatment Provenge in mid-November and hopes to get final FDA approval in the middle of next year. READ MORE>
NEW PROSTATE CANCER INFOLINK: It is worth remembering that Provenge is not a “drug” in any normal sense of the term. READ MORE>
Provenge is strictly a form of individual cell-based immunotherapy in which cells from the patient’s own body are extracted, modified, and then re-infused back into the patient.
Every single dose of Provenge therefore has to be individually created.
PROSTABLOG NZ: The pressure on NZ’s drug approval organisation, Pharmac, to fast-track Provenge to Kiwi patients is shaping to be another Herceptin debate.
In that case, it seems only a very loud and effective campaign by sufferers succeeded in getting the expensive breast cancer treatment past Pharmac’s drug subsidisation process.
If Provenge has to be individually manufactured for each patient, you can bet the doses will cost thousands of dollars.
Pharmac may be spared the dilemma beyond next year, since it seems the manufacturer will not be able to fulfill the demand in the US, let alone other countries.
Alternative business website purports to reveal scandal behind rival to Provenge’s eventual success
Posted in PROSTATE CANCER, Provenge, Treatment news, tagged Dendreon, drug scandal, FDA approval, Larry King Live, Market Rap.com, Michael Milken, Provenge, US Prostate Cancer Foundation, Wall Street Journal on September 6, 2009| Leave a Comment »
PROSTABLOG NZ: When global mainstream media reported the recent (partial) success of Dendreon drug company getting FDA approval for its new immunotherapy prostate cancer drug, Provenge, they didn’t mention how makers of a now-discredited rival drug may have delayed its path to chemist shops.
An “alternative” market investors’ website called Market Rap.com has just published a story by a former Wall Street Journal journalist that purports to reveal a murky background to what might be called – if it’s all, even partly, true – one of America’s biggest drug scandals.
It involves the US prostate Cancer Foundation (no relation to NZ’s) and its ubiquitous chairman, Michael Milken, who featured recently on the Larry King Live special about prostate cancer.
If you’ve got lots of time, READ MORE>